---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-007749"
form_type: "8-K"
ticker: "AEMD"
cik: "0000882291"
company_name: "AETHLON MEDICAL INC"
filed_at: "2026-10-09T20:15:22+00:00"
generated_at: "2026-10-12T15:10:04.224757+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Aethlon Medical boosts authorized common shares 10x to 200M, effective Oct 7

## Summary
- Authorized common stock, $0.001 par value, rises from 20,000,000 to 200,000,000 shares, amending Article V of the Articles of Incorporation.
- Stockholders approved the amendment at the 2026 Annual Meeting held October 1, 2026; Certificate of Amendment filed with the Nevada Secretary of State and effective October 7, 2026.
- Filing discloses no issuance, pricing, or intended use of proceeds for the newly authorized shares, and no corresponding financing was announced.
- Certificate of Amendment attached as Exhibit 3.1; filing signed October 9, 2026 by CEO and CFO James B. Frakes.

## SEC filing metadata
- accession: 0001683168-26-007749
- form_type: 8-K
- ticker: AEMD
- cik: 0000882291
- company_name: AETHLON MEDICAL INC
- filed_at: 2026-10-09T20:15:22+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/882291/000168316826007749/0001683168-26-007749-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/882291/000168316826007749/aethlon_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-007749
- JSON: https://secwatch.observer/filing/0001683168-26-007749.json
- Plain text: https://secwatch.observer/filing/0001683168-26-007749.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.